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lar endothelial cells derived from hypertensive and normoten-
sive rats. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): 
H2491-H2497, 1994.-The stroke risk factor hypertension 
may function as a predisposing agent by increasing the 
vulnerability of blood vessels to thrombosis or hemorrhage. 
The research here demonstrates that cerebrovascular endothe-
lial cells (EC) from spontaneously hypertensive (SHR) and 
Wistar-Kyoto normotensive (WKY) rats exhibit similar levels 
of adhesiveness for syngeneic peripheral blood monocytes (e.g., 
22.53 ± 1.32 and 24.35 ± 1.16%, respectively). Monocyte 
adhesion to SHR EC was dramatically increased by treatment 
of EC with lipopolysaccharide, interferon--y, or interleukin-1ß 
and tumor necrosis factor-a (e.g., 106, 68, and 171%, respec-
tively). Identical treatment of WKY EC also increased adhe-
sion albeit at significantly lower Ievels than observed on 
concomitantly tested SHR EC (e.g., 47.8, 12.7, and 60.7%, 
respectively). ABogeneie combinations of monocytes and EC 
again demonstrated significantly more upregulation of adhe-
sion by treatment of SHR EC than WKY EC. Characterization 
of these adhesive interactions revealed the interplay of adhe-
sion pathways, which include lymphocyte functional antigen-
1/intercellular adhesion molecule-1 (ICAM-1), Mac-1/ICAM-1, 
and very late activation antigen-4/vascular adhesion mol-
ecule-1 as weil as other undetermined mechanisms. In sum-
mary, these findings indicate hypertension may enhance re-
sponsiveness of endothelium to factors that promote monocyte 
adhesion. 
intercellular adhesion molecule-1; vascular adhesion mol-
ecule-1; tumor necrosis factor-a; interleukin-1ß; lipopolysac-
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ADHESNE INTERACTIONS involving peripheral blood mono-
cytes and vascular endothelium are important and early 
events under normal (steady-state) conditions as weil as 
in response to inflammation or vascular injury (4, 31). 
These adhesive interactions are mediated by surface 
molecules expressed by monocytes and endothelial cells 
(EC). These include lymphocyte functional antigen-1 
(LFA-1) (CD11a/CD18), Mac-1 <CD11b/CD18), p150,95 
(CD11c/CD18), very late activation antigen-4 (VLA-4) 
(CD49d/CD29), and sialyl LewisX molecules expressed 
by monocytes and intercellular adhesion molecule-1 
(ICAM-1) (CD54), ICAM-2, E-selectin, vascular adhe-
sion molecule-1 (VCAM-1), and granule membrane pro-
tein-140 (GMP-140) (CD62) expressed by EC (4, 8, 23). 
The expression of these molecules by vascular EC can be 
upregulated in vitro by a variety of factors such as 
interleukin-1ß (IL-1ß), tumor necrosis factor-a (TNFa), 
interferon-')' (IFN')'), and lipopolysaccharide (LPS) (11, 
16, 17, 22). The endothelial expression of molecules 
such as ICAM-1 and its ability to promote adhesion of 
peripheral blood monocytes, as well as other leukocytes, 
has been widely studied (3, 8, 11, 16). Adhesive interac-
tions involving vascular endothelium play important 
roles in a variety of disorders, including autoimmune 
murine Iupus nephritis (33), hemorrhagic shock (20), 
experimental allergic encephalomyelitis ( 12, 16), mul-
tiple sclerosis (28), and cerebral ischemic stroke (9). In 
particular, the role of monocyte-EC interactions in the 
pathogenesis of atherosclerosis has been widely studied 
(10, 14, 24). 
ICAM-1 expression by cultured cerebromicrovascular 
EC derived from spontaneously hypertensive rats (SHR) 
was shown to be more sensitive to cytokine-induced 
upregulation than similar cultures derived from normo-
tensive Wistar-Kyoto (WKY) and Sprague-Dawley (SD) 
rats (17). These findings may indicate a mechanism at 
least partially responsible for increases in in vivo perivas-
cular monocyte accumulation seen in hypertensive rats 
(15, 27). Some of these effects may be mediated by the 
production of proinflammatory factors such as TNFa, 
which is produced in greater amounts by SHR than by 
WKY rats when injected with LPS (26, 27). These 
observations indicate a possible mechanism by which 
hypertension may predispose to the development of 
disorders such as atherosclerosis as weil as stroke. 
Hypertension may be a risk factor by virtue of its ability 
to affect responsiveness of cerebrovascular EC to factors 
regulating interactions with monocytes. It is known that 
adhesion molecules other than just LFA-1/ICAM-1 or 
Mac-1/ICAM-1 (i.e., VLA-4/VCAM-1) are important in 
monocyte-EC interactions (3, 6, 19). The availability of 
cultured cerebrovascular EC allows for the determina-
tion of the relative importance of these pathways in the 
abovementioned cell interactions. In addition, the con-
comitant study of EC derived from normotensive and 
hypertensive rats permits direct comparison of their 
capacity to respond to various stimuli. 
METHODS 
Rats. Fernale WKY and SHR rats obtained from Taconic 
Farms (Germantown, NY) and SD rats obtained from Harlan 
Sprague Dawley (lndianapolis, IN) were used at 12-14 wk of 
age to isolate cerebromicrovascular EC and peripheral blood 
monocytes. All animal procedures were performed in accor-
dance with the NIH "Guide for the Care and Use of Labora-
tory Animals" [Departrnent of Health and Human Services 
(NlH) Publication No. 86-23, Revised 1985J. 
Cerebromicrovascular EC cultures. The isolation and culti-
vation of cerebromicrovascular EC from SHR, WKY, and SD 
rats were performed with some modification as previously 
described (29). All EC cultures routinely exhibited characteris-
tic cobblestone appearances and were used at the time they 
attained confluence on 96-well flat-bottom microtiter plates. 
Cultures contained > 95% EC identified by immunocytochem-
istry and ftuorescence-activated cell sorter (F ACS) analysis 
using EC-specific anti-factor VIII-related antigen (Accurate 
Chemical and Scientific, Westbury, NY). EC cultures used in 
experiments described here were obtained from three separate 
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lines ( 1line for SD EC) and were used at third through seventh 
passages. 
Before use in adhesion assays, EC monolayers were washed 
twice with warm Hanks' balanced saline solution (HBSS) 
followed by incubation in media alone or with indicated 
concentrations of recombinant IFN-y (Genzyme, Boston, MA), 
human IL-1 ß (Endogen; Boston, MA), recombinant human 
TNFa (Endogen), or lipopolysacharide (LPS, Sigma, St. Louis, 
MO). The media consisted ofmedium 199 (M-199) (containing 
25 mM N-2-hydroxyethylpiperazine-N' -2-ethanesulfonic acid 
buffer, Earle's salts, and L-glutamine) with 20% heat-
inactivated fetal calf serum (FCS), 90 ~g/ml heparin, 100 
~g/ml Streptomycin, 100 U /ml penicillin G, and 0.25 ~g/ml 
amphotericin B as fungizone (all from GIBCO, Long Island, 
NY), and 20 ~g/ml endothelial cell growth supplement (Collabo-
rative Research; Bedford, MA). All cytokines contained < 10 
pg/ml endotoxin as determined by E-toxate assay kit (Sigma). 
I CAM -1 expression by EC cultures was quantitated by enzyme-
linked immunosorbent assay as previously described (30). 
Monocytes. Peripheral blood was obtained from rats by 
cardiac puncture and collected into heparin-coated tubes. 
Mononuclear cells were isolated by Ficoll-Hypaque density 
gradient centrifugation (Histopaque 1119/Histopaque 1077; 
Sigma) for 30 min at 700 g, 24°C. Mononuclear cells separated 
from plasma, and granulocytes were collected, washed, and 
further purified by centrifugation on hyperosmotic Nycodenz 
density gradients (Accurate Chemical, Westbury, NY) for 15 
min at 600 g, 24°C. Monocyte preparations were extensively 
washed in PBS containing 0.5% bovine serum albumin (BSA) 
and 2% EDTA to remove contaminating platelets. The mono-
cyte-enriched fractions were counted ( > 95% viable as deter-
mined by trypan blue exclusion), and their purity was assessed 
as > 90% by their ability to phagocytize Iatex beads and by 
FACS analysis using an antibody to rat monocytes and macro-
phages (ED-1) (see Table 1). 
Monocyte adhesion. Adhesion experiments were performed 
using monocytes labeled with sodium [51Cr ]chromate (0.1 
mCi/ml, 30 min, 37°C). Cells were washed twice and resus-
pended (usually 4-10 x 105/ml) in M-199. Before the addition 
of monocytes, EC cultures were washed twice with warm 
HBSS containing 4% FCS. Monocytes were added (50 ~1/well), 
and plates were incubated at 37°C for 30 min. Mter incuba-
tion, nonadherent cells were removed, and monolayers were 
gently washed twice with warm M-199. The adherent cells 
were lysed by overnight incubation with 2% (vol/vol) Triton-X 
<0.2 ml/well), and radioactivity in all fractions was counted on 
Table 1. Expression of adhesion molecules by SHR, 
WKY, and SD monocyte populations 
Positively Stained Cells, % 
MAb 
SHRMo WKYMo SDMo 
ED-1 90.3 (142.3) 89.6 (129.3) 92.7 (123.6) 
ED-2 11.3 (19.60) 8.7 09.7) 7.9 (23.2) 
CDlla 81.4 (168.3) 77.6 (156.9) 68.4 (160.0) 
CDllb 84.4 (151.7) 86.0 (141.8) 70.6 (124.4) 
CD18 79.6 (237.4) 86.5 (183.7) 72.4 (133. 7) 
CD 54 32.0 (108.4) 41.5 (123.5) 40.6 (159.5) 
VLA-4 28.2 (31.6) 22.4 (25.9) 23.3 (27.0) 
Expression of indicated markers on freshly prepared peripheral 
blood monocytes (Mo) were analyzed by flow cytometry. Data from one 
representative experiment are presented as percentage of positively 
stained cells with mean fluorescence intensity values in parentheses as 
described in METHODS. Freshly prepared Mo were incubated with 
indicated monoclonal antiborlies (MAb) as described in METHODS. SHR, 
spontaneously hypertensive rats; WKY, Wistar-Kyoto rats; SD, 
Sprague-Dawley rats. VLA-4, very late activation antigen-4. 
a LKB Compugamma 1282 gamma counter. The percentage of 
adherent cells was calculated by dividing Triton-X counts per 
minute by the total counts per minute added. All experiments 
were performed in quadruplicate. 
Because monocyte preparations were partially contami-
nated with lymphocytes, which also adhere to endothelium, 
some experiments calculated adhesion by measuring myeloper-
oxidase (MPO) activity (2), which is present in monocytes and 
granulocytes, but not lymphocytes. No significant variations 
in the percent adhesion were observed using radioactivity data 
and data assessing MPO activity. Also, ED-1 staining of EC 
monolayers after addition of monocytes showed that < 10% of 
the adhering cells were unstained, indicating that adhesion by 
contaminating lymphocytes was not a factor under the condi-
tions used here. 
Antibody-blocking experiments. Before addition to EC mono-
layers, monocytes were preincubated in serum-free media for 
20 min at 37°C with saturating concentrations (10-30 ~g/m)) 
of indicated monoclonal antibodies (MAbs) or in serum-free 
medium alone. Isotype-matched antiborlies were used as con-
trols and found to have no significant effects compared with 
untreated monocytes. In blocking experiments using anti-
ICAM-1(1A29), EC monolayers were preincubated with an 
antibody for 30 min and washed three times with warm HBSS 
containing 4% FCS before addition of monocytes. Adherence 
was determined as described above, and inhibition was cal-
culated by the formula: 100% x [%adhesion (no MAb) -
%adhesion ( + MAb)]/%adhesion (no MAb). 
Flow cytometry. Analysis of cell surface molecule expression 
on peripheral blood monocytes freshly prepared from both 
SHR and WKY rats was performed by staining with antihoclies 
as described below (1:200-1:500 dilution; except clone WT.5, 
which was used at 1:50) for 0.5-1 hat 4°C. Mter beingwashed 
(PBS containing 0.02 mM sodium azide, 1% BSA) and incu-
bated (30 min, 4°C) with 1:50 rhodamine-conjugated goat 
F(ab')2 anti-mouse immunoglobulin (lg)G (Accurate), cells 
were washed and analyzed by flow cytometry using a F ACS IV 
analyzer (Becton Dickinson FACS System, Mountain View, 
CA). The data are presented as percentage of cell population 
positively stained and mean fluorescence intensity (MFI) 
representing semiquantitative data (in channel units) on the 
mean number of fluorescent reagent-binding molecules ex-
pressed by the cells. 
Antibodies. Anti-rat ICAM-1 (CD54; clone 1A29), anti-rat 
VLA-4 (CD49d; clone TA-2), anti-rat LFA-la chain (CDlla; 
clone WT.1), and anti-rat LFA-1ß chain (CD18; clone WT.3) 
are mouse IgGl; anti-rat Mac-la chain (CDllb; clone WT.5) is 
a mouse IgA. All antibodies were obtained from Seikagaku 
America (Rockville, MD). Monoclonal anti-rat ED-1 and anti-
rat ED-2 are both mouse IgG1 antibodies obtained from 
Biosource International (Camarillo, CA). 
RESULTS 
Purified populations of unstimulated monocytes from 
SHR, WKY, and SD rats were > 90% monocytes as 
judged by their expression of ED-1 antigen, which is 
present on monocytes and macrophages but not granulo-
cytes (Table 1). Only a small percentage of cells stained 
positively for ED-2, which is expressed by macrophages 
but not monocytes or granulocytes. The monocyte popu-
lations from all three rat strains also contained many 
cells positively stained for adhesion molecules CDlla 
(LF-la), CDllb (Mac-la), and CD18 (LFA-lß). A some-
what smaller percentage of cells stained positively for 
ICAM-1 (CD54) and even fewer for VLA-4 (CD49d). In 
experiments performed on other monocyte preparations 
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from the same rat strains, the relative degree of expres-
sion of the listed markers was similar except for the 
expression ofVLA-4 and ICAM-1, which fluctuated by as 
muchas20%. 
The adherence of peripheral blood monocytes freshly 
isolated from SHR and WKY rats was determined using 
syngeneic EC monolayers. In these experiments, the 
number of monocytes that adhered to EC monolayers 
was directly proportional to the number of monocytes 
added (Fig. 1). The percentage of adherent monocytes 
within a given population was constant over a wide 
range of concentrations {1-7.5 x 104 monocytes/ 
microtiter weil). The use of > 8 x 104 monocytes yielded 
significant changes in the percentage of adherent mono-
cytes, which were probably due in part to overcrowding 
and to the adherence of monocytes to monocytes already 
adhering to EC monolayers (observed by light micros-
copy). In different experiments, the percentage ofmono-
cytes that adhered to unstimulated EC monolayers 
varied only slightly (Fig. 1). These variations were 
dependent on the EC culture (i.e., passage number) and 
the monocyte preparation. 
In a representative experiment (Fig. 2), there were no 
significant differences in the binding Ievels of peripheral 
blood monocytes freshly isolated from SHR and WKY 
rats to syngeneic monolayers of unstimulated EC (i.e., 
22.73 ± 1.42 and 25.33% ± 1.26, respectively). In four 
separate experiments, which used EC cultures estab-
lished and passaged simultaneously and monocytes iso-
lated from age-matched and identically treated rats, no 
significant differences were observed in the basallevel of 
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Fig. 1. Effect ofnumber ofmonocytes added on number ofmonocytes 
adhering to unstimulated syngeneic endothelial cell (EC) monolayers. 
Monocytes freshly prepared from peripheral blood of spontaneously 
hypertensive rats (SHR, o, O) and Wistar-Kyoto (WKY, •· e) rats 
were added to syngeneic EC monolayers. Results are from 2 separate 
experiments (expt 1, solid lines; expt 2, dashed lines). Each point 
represents mean of quadruplicate wells (all means ± SE values were 
within 10% ofthe mean). Nurobers ofmonocytes were determined by 
evaluation of standards that measured ratio of counts per minute of Cr 
per cell counts. Estimates by microscopic evaluation of ED-1 positive 
cells were similar to determinations by radioactive counting. 
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Fig. 2. Effect of EC stimulation on SHR and WKY monocyte binding 
to syngeneic EC. EC monolayers derived from SHR (A and B) and 
WKY (C and D) rat cerebral microvessels were treated for 4 h (A and 
C) or 20 h (B and D) with 100 U/ml interferon (IFN), 100 ng/ml 
lipopolysaccharide (LPS), or 100 U/ml tumor necrosis factor (TNF) + 
40 U/ml IL-1. Data are means ± SE of quadruplicate wells obtained 
from a single representative experiment (* P = < 0.01, ** P = < 0.001; 
Student's t-test). 
SHR or WKY monocyte adhesion to untreated EC 
monolayers. 
The treatment of EC cultures with LPS, IFN-y, or 
TNFo: + IL-lß for 4 or 20 h increased their adhesiveness 
for monocytes (Fig. 2). The increase in SHR monocyte 
adhesion to TNFo: + IL-1ß-treated SHR EC (> 150%) 
was significantly greater (P < 0.001) than that observed 
with WKY monocytes to similarly treated WKY EC 
(55%). This greater responsiveness of SHR EC was 
observed for all treatments and was significant at both 
4- and 20-h time periods. Similar results were also 
observed in experiments using other monocyte prepara-
tions and EC cultures. 
To assess whether this difference is attributable to 
monocytes or EC, a direct comparison ofthe adhesion of 
SHR and WKY monocytes was performed by simul-
taneously assessing adhesion to syngeneic as weil as 
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allogeneic EC monolayers. The results demonstrate that 
both monocyte populations exhibited increased adhesive-
ness to stimulated (20 h) allogeneic EC monolayers (Fig. 
3). The increased adhesiveness followed the same pat-
tern as was seen in the syngeneic combinations (i.e., 
TNFo: + IL-lß > LPS > untreated). The relative 
increase in adhesion of either monocyte population to 
stimulated SHR EC was significantly greater than was 
observed with WKY EC (P < 0.001). Similar results 
were also observed using EC treated for 4 h and in 
identical experiments performed using different mono-
cyte preparations and EC lines (results not shown). 
Peripheral blood monocytes freshly isolated from SD 
rats also adhered to a significantly greater degree to 
treated SHR EC than to treated WKY or SD EC (Table 
2). The quantitative Ievel of upregulation of SD EC 
adhesiveness by TNFo: + IL-1ß was similar to that 
observed with WKY EC. In all cases, the relative in-
creases in adhesion as a result of EC treatment were 
significantly greater for SHR EC than for WKY or SD 
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Fig. 3. Effect of EC stimulation on SHR and WKY monocyte binding 
to allogeneic and syngeneic EC. Freshly prepared peripheral blood 
monocytes from SHR CA) and WKY (8) rats were concomitantly 
allowed to adhere to EC monolayers derived from SHR (open bars) and 
WKY (hatched bars) rat cerebral microvessels treated for 20 h with 
100 ng/ml LPS or 100 U/ml TNF + 40 U/ml IL-1. Data are means ± 
SE of quadruplicate wells obtained from a single representative 
experiment (* P = < 0.01, •• P = < 0.001; Student's t-test). 
Table 2. Enhancement of monocyte adhesion to 
stimulated SHR, WKY, and SD cerebrovascular 
ECcultures 
Increased Adhesion, % 
EC Treatment 
SHREC WKYEC SDEC 
SHR monocytes 
LPS 106.3 72.8* 66.7* 
TNF+ IL-1 170.5 117.2* 109.6* 
IFN 68.0 34.8* ND 
WKY monocytes 
LPS 76.1 47.8* 41.9* 
TNF+IL-1 93.2 60.7* 54.0* 
IFN 14.6 12.7 ND 
SD monocytes 
LPS 80.3 40.9* 51.3* 
TNF+IL-1 89.0 54.9* 69.1* 
Data from 3 separate experiments were pooled and are presented as 
percentage of increased adhesion according to the formula: 100% x [% 
adhesion (test) -% adhesion (control))/% adhesion (control). Control 
values for adhesion of SHR, WKY, and SD monocytes to unstimulated 
endothelial cells (EC) were not significantly different and ranged 
between 14.83 and 23.96%. Cerebrovascular EC cultures were incu-
bated for 20 h with indicated factors at the following concentrations: 
100 ng/mllipopolysaccaride (LPS); 100 U/ml tumor necrosis factor 
<TNF) + 40 U/ml interleukin-1 {IL-1); or 100 U/ml interferon (IFN). 
* Significant (2-way analysis of variance and Bonferroni correction; P 
< 0.001) differences between SHR EC and WKY or SD EC in the 
Ievels of upregulated monocyte adhesion for each respective EC 
culture. ND, not done. 
EC (2-way analysis of variance and Bonferroni correc-
tion; P < 0.001). 
The adhesion molecules responsible for the observed 
monocyte-EC interactions were studied by antibody-
blocking experiments. The adherence of WKY mono-
cytes to unstimulated WKY EC monolayers was par-
tially inhibited (10.7 and 42.7%) by incubation of 
monocytes with MAb against a-chains of LF A-1 or 
Mac-1, respectively (Table 3). lncubation with antiborl-
ies to the common ß-chain (CD18) ofthese two adhesion 
molecules inhibited adhesion by > 50%. An antibody 
Table 3. Effect of anti-adhesion antibody treatment on 
WKY monocyte adhesion to syngeneic cerebrovascular 
ECcultures 
Antibody EC Treatment 
Treatment None TNF + IL-1 <4 h> TNF + IL-1 <20 h> 
None 22.5 33.6 38.5 
CD18 10.2 (54.7) 27.1 (19.4) 34.6 (10.1) 
CDlla 20.1 (10.7) 31.4 (6.6) 36.4 (5.5) 
CD11b 12.9 (42.7) 27.6 (17.9) 33.3 (13.5) 
VLA-4 23.1 (0) 30.9 (8.1) 33.8 (12.2) 
CD18/VLA-4 11.3 (49.8) 22.0 (34.5) 21.9 (49.4) 
ICAM-1 11.1 (50.7) 26.3 (21.7) 33.7 (12.1) 
Data are presented as percent adhesion calculated as described in 
METHODS. Cerebrovascular EC culture monolayers were incubated for 
4 or 20 hin the absence or presence of 100 U/ml TNF + 40 U/ml IL-1. 
Numbers in parentheses represent percent inhibition, which was 
calculated according to the formula: 100% x [%adhesion (no 
MAb)- %adhesion (+MAb)]/%adhesion (no MAb). Monocytes or EC 
were incubated with indicated MAbs as described in METHODS. ICAM-1, 
intercellular adhesion molecule-1. 
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directed against rat VLA-4 had no effect on adhesion to 
unstimulated EC monolayers. The combination of anti-
hodies to CD18 and VLA-4 did not further enhance the 
inhibition of monocyte adhesion that was observed by 
treatment with anti-CD18 alone (Table 3). The capacity 
of antibody to ICAM-1 toblock monocyte adhesion to 
untreated EC monolayers was equal to the inhibition 
observed with antihoclies to its ligands (CD11a/CD18 
and CD11b/CD18), which are present on the monocytes. 
The findings also indicate that an additional ICAM-1 
Iigand (i.e., p150,95 o:-chain; CD11c) probably does not 
play a major role in monocyte adhesion to nonstimu-
lated EC. 
The treatment of monocytes with anti-adhesion mol-
ecule antihoclies inhibited adhesion to cytokine-treated 
EC to varying degrees. The ability to block adhesion 
mediated by LFA-1/ICAM-1 or Mac-1/ICAM-1 signifi-
cantly dropped with increasing time of incubation (i.e., 
anti-CD18 inhibited adhesion 54.7, 19.4, and 10.1% to 
EC monolayer untreated or treated with TNFo: + IL-1ß 
for 4 and 20 h, respectively). Similar findings were 
observed with treatment of EC monolayers with anti-
ICAM-1. In addition, the adhesion of monocytes to 
treated EC monolayers became increasingly sensitive to 
inhibition by antibody to VLA-4. Finally, the combina-
tion of anti-CD18 and anti-VLA-4 was significantly less 
effective at inhibiting monocyte adhesion to EC treated 
for 4 h with TNFo: + IL-1ß (34.5%) than to EC treated 
for 20 h or untreated (49.4 and 49.8%, respectively). 
Very similar Ievels of inhibition by antibody treatment 
were observed in experiments using different WKY EC 
cultures. 
An almost identical pattern of inhibition by antiborlies 
was observed using SHR monocytes and SHR EC mono-
layers (Table 4). Although the degree ofupregulation of 
adhesion with TNFo: + IL-lß was considerably greater 
in these cultures than in the WKY cultures shown in 
Table 2 (i.e., 87.1 vs. 49.3% at 4 h and 120.7 vs. 71.1% at 
20 h, respectively), there were no significant differences 
in the relative capacity of antiborlies to inhibit adhesion. 
The data shown in Table 4 are representative of experi-
ments performed on three different SHR EC cultures. 
Table 4. Effect of anti-adhesion antibody treatment on 
SHR monocyte adhesion to syngeneic cerebrovascular 
ECcultures 
Antibody EC Treatment 
Treatment None TNF + IL-1 (4 h) TNF + IL-1 (20 h) 
None 21.7 40.6 47.9 
CD18 11.6 (46.5) 32.0 (21.2) 42.6 (11.1) 
CDlla 18.9 (12.9) 38.1 (6.2) 45.9 (4.2) 
CDllb 13.0 (40.1) 31.6 (22.2) 40.8 (14.8) 
VLA-4 21.9 (0) 36.4 (10.3) 40.1 (16.3) 
CD18/VLA-4 11.3 (47.9) 26.5 (34.7) 25.9 (45.9) 
ICAM-1 10.5 (51.6) 31.3 (22.9) 40.9 '04.6) 
Data are presented as percent adhesion calculated as described in 
METHODS. Cerebrovascular EC culture monolayers were incubated for 
4 h or 20 hin absence or presence of 100 U/ml TNF + 40 U/ml IL-1. 
Numbers in parentheses represent percent inhibition, which was 
calculated according to the formula: 100% x [%adhesion (no 
MAb)- %adhesion (+MAb)]/%adhesion (no MAb). Monocytes or EC 
were incubated with indicated MAbs as described in METHODS. 
DISCUSSION 
The experiments here demonstrate that stimulation 
ofEC monolayers (LPS or TNFa + IL-1ß) considerably 
increased syngeneic monocyte adhesion to SHR EC to a 
greater degree than to WKY EC (Fig. 2). Similar results 
were obtained using allogeneic combinations of mono-
cytes and EC (Fig. 3, Table 2), indicating that these 
differences are directly related to the responsiveness of 
the EC cultures. 
A possible explanation for these findings involves the 
expression of adhesion molecules such as ICAM-1. This 
molecule is known tobe expressed by brain EC (12, 16, 
17, 28) and implicates these cells in interactions with 
peripheral blood lymphocytes, monocytes, and neutro-
phils that express CD11a, CD11b, and CD18 integrins 
(3, 8, 11, 19). The involvement ofiCAM-1 and its ligands 
in monocyte-EC interactions described here was exam-
ined by antibody-blocking studies. These experiments 
may also discern which specific adhesion pathways are 
responsible for the enhanced adhesiveness of treated 
SHR EC. The results showed that -50% of monocyte 
adhesion to unstimulated EC monolayers was due to 
Mac-1 (CD11b/CD18) and, to a lesser extent, LFA-1 
(CD11b/CD18) interactions with ICAM-1. Antibody-
blocking experiments were also performed on EC treated 
with TNFo: + IL-1ß for 4 and 20 h. Although either of 
these cytokines alone similarly affected EC cultures, 
maximal responses were obtained with mixtures ofboth 
cytokines. In addition, these cytokines were used in 
combination, since both are concomitantly produced 
and most often present together. Considerably de-
creased blocking by treatment with above antihoclies 
wasseenon EC treated with TNFo: + IL-1ß. This result 
indicated either a decrease in the role for these adhesion 
molecules or, more lik.ely, the emergence of additional 
adhesion pathways responsible for monocyte-EC interac-
tions. The observation that stimulated EC express even 
more ICAM-1 (16) strongly suggest the latter. 
Antibody-blocking studies also showed that treatment 
of EC with TNFo: + IL-1ß resulted in time-rlependent 
increases in sensitivity to blocking by VLA-4 antibody. 
These data suggest that monocyte interactions with 
stimulated but not unstimulated EC are partially depen-
dent on VLA-4 expressed by the monocyte and implicate 
the EC expression ofVCAM-1 (a Iigand for the integrin 
VLA-4) in interactions between monocytes and stimu-
lated EC. The expression of VCAM-1 by EC has been 
described (6, 7, 18). The observation that VLA-4 is 
expressed on freshly prepared monocyte preparations 
(Table 1), and the Iack of an effect ofVLA-4 antibody on 
adhesion to unstimulated EC suggest the absence of 
VCAM-1 expression on unstimulated brain microvessel 
EC. Little to no VCAM-1 is expressed on unstimulated 
endothelium (3, 7, 19). However, its expression by EC is 
induced by cytokine treatment (6, 7, 18), and this 
implicates stimulated EC in interactions with cells 
expressing VLA-4, including resting lymphocytes and 
monocytes but not granulocytes (6, 21). A pathogenic 
role for VCAM-1 in monocyte adhesion is implicated by 
its expression on endothelium during early atheroscle-
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rotic lesion formation in hypercholesterolemic (dietary-
induced) and Watanabe heritable hyperlipidemic rabbits 
(heritable models) (10). 
Treatment of monocytes with either VLA-4 antibody 
or CD18 antibody had relatively little effect on adhesion 
to stimulated EC, whereas the combination of both 
antiborlies inhibited adhesion by almost 50% (Tables 3 
and 4). Similar findings have been reported in sturlies 
examining monocyte adhesion to human umbilical vein 
endothelial cells (6, 19) and imply the coincident expres-
sion of two operational pathways for monocyte adhe-
sion. The inability of the above two monoclonal antiborl-
ies to totally block adherence indicate that other 
molecules are also involved in the interactions reported 
here. The in vivo relevance of these findings is shown by 
experiments demonstrating inhibition of monocyte emi-
gration into inflamed rabbit peritoneum by intravenous 
infusion of MAb to CD18 and VLA-4 (32). The Iack of 
any effect by treatment with individual MAbs implies 
that blockade of both pathways is required to suppress 
extravasation of monocytes. Interestingly, the treat-
ment of monocytes with the combination of antiborlies 
to CD18 and VLA-4 inhibited adhesion to EC treated for 
20 h to a significantly greater extent than to EC 
similarly treated for 4 h (Tables 3 and 4). Early and 
transient expression of other adhesion molecules by 
stimulated EC may account for this observation. A 
possible candidate molecule would be E-selectin, which 
is synthesized de novo by cytokine-treated EC, is tran-
siently expressed on EC (2-8 h), and interacts with 
circulating blood cells that express sialyl LewisX (i.e., 
monocytes) (5, 6, 18). 
Although a role for ICAM-1 (and possibly VCAM-1) in 
cytokine-mediated monocyte adhesion in this system is 
established, the involvement ofthese molecules in migra-
tion is unknown. It is also not known if these same 
factors will similarly affect EC derived from different-
sized vessels. The most interesting observation de-
scribed here is that adhesion of any particular monocyte 
preparation to treated SHR EC is greater than to 
similarly treated WKY or SD EC (Table 2). This en-
hanced responsiveness of EC may be due to a factor 
related to hypertension. More conclusive evidence awaits 
testing of other hypertensive and normotensive rat 
strains, as weil as experiments utilizing experimentally 
induced hypertension models and hypertensive strains 
treated with antihypertensive medications. 
It is interesting that all experiments concomitantly 
performed using SHR and WKY monocytes also indicate 
some differences in the capacity of monocytes to adhere 
to stimulated EC. In examining the adhesion of these 
monocyte populations to syngeneic and allogeneic EC, 
the adhesion of unstimulated SHR monocytes to treated 
EC was consistently and significantly more upregulated 
than that observed for unstimulated WKY monocytes on 
the same EC. Although monocyte preparation proce-
dures were minimized to prevent activation, the pres-
ence of ED-2 positive cells and the expression of VLA-4 
antigen may indicate that some activation did occur. In 
addition, incubation of monocytes on EC monolayers for 
30 min as is typical for adhesion assays is a suitable 
length oftime for activation to occur. It is interesting to 
note that actually lower Ievels of CD11b/CD18 were 
expressed by leukocytes from stimulated hypertensive 
rats (1). 
The comparison of monocyte adhesion to cerebromi-
crovascular EC from normotensive (WKY, SD) and SHR 
provides a unique opportunity to examine the contribu-
tion of hypertension to pathogenic mechanisms, which 
may affect the vascular endothelium. Despite the fact 
that no significant variations were observed in the 
quantitative dependence on any particular adhesion 
pathway utilized by SHR or WKY EC (antibody-blocking 
experiments) other differences could exist in vivo, where 
endothelium is subjected to shear stress and factors 
other than just cytokines. Another in vivo difference not 
addressed in vitro is related to the finding of substan-
tially greater numbers of monocytes in SHR, which 
would increase the number of cell interaction events 
(25-27). Additional sturlies may identify other mecha-
nisms through which factors such as hypertension 
contribute to the initiation ofvascular injury and contrib-
ute to pathological changes seen in stroke and reperfu-
sion injury. 
In summary, monocytes and ECs from hypertensive 
animals show a greater capacity for upregulation of 
adhesive interactions in response to several agonists 
than similar cells from normotensive animals. En-
hanced monocyte interaction with endothelium in seg-
ments of the vasculature may signify the ease at which 
overall disturbances of endothelium can occur. This 
increased sensitivity of SHR EC may represent a mecha-
nism by which hypertension acts as a predisposing 
factor for the development of thrombotic vascular dis-
ease (13, 15, 26). 
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